IL7R and colonic neoplasm: Moreover, lower frequencies of PB-circulating CD127+ lymphocytes (< 5%) were associated with beneficial survival in rectal and breast cancer patients, but not in patients diagnosed with liver, gastric, esophageal, ovarian, or colon cancer (106).